相关实验视频
Updated: Jul 27, 2026
08:10
Environmentally Induced Heritable Changes in Flax
Published on: January 26, 2011
10.5K
由LrGSTU181过度表达在Lolium刚性中所赋予的迪克洛福甲基耐药性
Hong Qian1, Yalin Zeng2, Hui Zhao3
1College of Plant Protection, Hunan Agricultural University, Changsha 410128, China.
Pesticide biochemistry and physiology
|December 5, 2025
概括
这项研究确定了LrGSTU181,一种谷氨酸S转移酶 (GST),作为一种关键的酶,它赋予了Lolium rigidum中除草剂二洛甲基的耐药性. 这一发现扩大了我们对这种重要的农业杂草中代谢抵抗机制的理解.
科学领域:
- 植物科学 植物科学
- 生物化学 生物化学
- 农业科学 农业科学
背景情况:
- 硬 (Lolium rigidum) 由于对除草剂耐药性增加,对全球农业经济构成重大威胁.
- 澳大利亚L. rigidum种群WALR70对二洛甲基表现出非位抗性 (NTSR),需要对其潜在机制进行调查.
研究的目的:
- 阐明在澳大利亚L. rigidum种群WALR70.0.中赋予迪克洛福-甲基耐受性的特定耐药性机制.
- 为了识别和功能性地描述参与这种非点抗性的基因和酶.
主要方法:
- 对抗性 (WALR70) 和敏感性 (SVLR1) 种群之间的酶活性进行比较分析.
- 使用RNA测序 (RNA-seq) 和定量实时PCR (RT-qPCR) 的基因表达概况.
- 候选基因 (LrGSTU181和UGT79) 通过酵母和大米的异质表达和分子对接研究的功能验证.
主要成果:
- 在耐药人群中,谷氨酸S转移酶 (GST) 酶活性显著增加 (2.8倍).
- 一个tau类GST基因,LrGSTU181,在耐药人群中被发现显著上调.
- 转化为LrGSTU181的酵母和大米对二洛甲基有增强的耐受性,分子对接证实了LrGSTU181与二洛酸的高亲缘关系结合.
结论:
- 类谷氨酸S转移酶LrGSTU181在功能上被确立为Lolium rigidum中迪克洛福普甲基耐药性的调解者.
- 这一发现扩大了这种经济重要杂草物种非位抗性 (NTSR) 的已知的代谢基础.
- 了解LrGSTU181的作用为管理农业中狄克洛甲基耐药性的潜在目标提供了帮助.
相关概念视频
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...